title: Product development programs for neglected tropical diseases: A crucial role for expert meetings.
authors.affiliation: Lygature, Utrecht, The Netherlands.
authors.forename: Leonie
authors.initials: L
authors.lastname: Hussaarts
authors.affiliation: Lygature, Utrecht, The Netherlands.
authors.forename: Kim
authors.initials: K
authors.lastname: van der Weijde
authors.affiliation: Global Health R&D Department, Coinsins, Switzerland, being part of the biopharma business of Merck KGaA, Darmstadt, Germany.
authors.forename: Pierre
authors.initials: P
authors.lastname: Dome
authors.affiliation: Global Health R&D Department, Coinsins, Switzerland, being part of the biopharma business of Merck KGaA, Darmstadt, Germany.
authors.forename: Elly
authors.initials: E
authors.lastname: Kourany-Lefoll
authors.affiliation: Global Health R&D Department, Coinsins, Switzerland, being part of the biopharma business of Merck KGaA, Darmstadt, Germany.
authors.forename: Jutta
authors.initials: J
authors.lastname: Reinhard-Rupp
authors.affiliation: Lygature, Utrecht, The Netherlands.
authors.forename: Remco
authors.initials: R
authors.lastname: de Vrueh
mesh_terms: D003299:Cooperative Behavior; D017277:Drug Approval; D004345:Drug Industry; D005104:Expert Testimony; D014943:Global Health; D006291:Health Policy; D006801:Humans; D058069:Neglected Diseases / Q000188:drug therapy*; D014330:Tropical Medicine; D014944:World Health Organization